Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy.
about
Methotrexate for high-grade osteosarcoma in children and young adultsMethotrexate for high-grade osteosarcoma in children and young adultsRegression tree construction by bootstrap: model search for DRG-systems applied to Austrian health-dataChallenges in conducting clinical trials in children: approaches for improving performancePrescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidancePopulation pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer.Paediatric models in motion: requirements for model-based decision support at the bedside.Clinical trials in the era of personalized oncology.Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Modeling NSCLC progression: recent advances and opportunities availableRisk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients.Optimizing drug development of anti-cancer drugs in children using modelling and simulation.The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.DIMETER: a haptic master device for tremor diagnosis in neurodegenerative diseases.Dashboard systems: implementing pharmacometrics from bench to bedside.Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies.Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.Pharmacokinetic modeling of therapies for systemic lupus erythematosus.Developing Exposure/Response Models for Anticancer Drug Treatment: Special ConsiderationsClinical Decision Support Tools: The Evolution of a Revolution.Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.A web-based knowledge management system integrating Western and Traditional Chinese Medicine for relational medical diagnosis.Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting.Novel method to predict body weight in children based on age and morphological facial features.Physiologically based pharmacokinetic modeling for predicting irinotecan exposure in human body.Key performance indicators for the assessment of pediatric pharmacotherapeutic guidance.Critical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and Future.Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.
P2860
Q24234472-79239925-2B9D-4840-AA35-45600A0A4F8EQ24241431-9447FBAB-A126-4EA2-8104-4B7D7E5440DEQ33528307-EBC9F0D0-1086-475D-9EF3-3B224BF3E681Q33717140-D6E3427E-1A67-4D3C-B2C2-4D52D8960859Q33860506-82EF49E8-F301-4E39-B157-64401CDBA82EQ33888004-942820BD-7DA9-445D-BC74-16CD05F99596Q34780653-FA711289-B7CD-449A-A14C-CA337A81337EQ34953686-731A8363-91A4-4429-8E3C-D8396A3E5DD2Q35555963-9BAA2664-18D8-4C7A-916F-ED8FAA9FB086Q36473125-18DA0F56-7927-4CEB-93DE-0CD8C151CFFEQ36777485-46C0E881-C991-458D-84FC-3F1AA6DFE5A0Q36910615-16D8DE4B-8AC6-4F2E-9B00-274077275FD5Q36951924-76A848EA-19CE-4E60-B922-D6D3BAD1826BQ36987975-0C3211F7-738C-46BB-9DC4-66053748F26CQ37521422-5B104DF8-966D-4704-9C9C-4CE137C52980Q37692028-DA095295-8AD7-4901-B7D2-958A66581599Q37731026-04040240-DCCB-499A-88B4-ABA2DC4DA878Q38221759-2A141EC2-4631-417D-A476-41EBA2A97EE9Q38364464-8AE84DD4-87BD-43DC-98AC-0A333066EA14Q38527434-06D92EA7-0948-4F7F-8BB9-5544D4BCDF75Q38542910-0C6A099E-8B1E-4CE8-B996-D272F3F8429EQ38557331-6CC3C928-57D1-4F82-804E-B5BB2E47A665Q38702792-7DB9CCF1-53FC-49C5-9E97-7EBD08B5EED7Q38759413-2365AF88-52FB-41BB-8255-B8D1D962BF71Q39241359-9BE35134-8DD2-4EFF-B1E7-3D62F8E93A3AQ39957079-31679A08-3F30-4921-ABFB-AC9FD4736EEEQ40232795-ECB1A790-AF9B-4182-B3B8-710D09363EB5Q41471506-5A275878-AFBB-49E6-93BA-7DD951AB2F10Q42059987-1403961E-0FA7-4A76-BEB3-2C2BDFDC85B6Q47943868-0EAD970A-AFDC-47A8-870B-A56099B17232Q50924228-1D1934D6-4740-4B4F-B506-5F24816F5373
P2860
Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@ast
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@en
type
label
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@ast
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@en
prefLabel
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@ast
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@en
P2093
P2860
P356
P1476
Integration of modeling and si ...... ing pediatric pharmacotherapy.
@en
P2093
Jeffrey S Barrett
John T Mondick
Kalpana Vijayakumar
Mahesh Narayan
Sundararajan Vijayakumar
P2860
P2888
P356
10.1186/1472-6947-8-6
P577
2008-01-28T00:00:00Z
P5875
P6179
1042448500